Similar articles for PMID: 7652925

Year	Number of Results
1974	1
1982	1
1985	1
1989	1
1990	1
1992	1
1993	2
1994	4
1995	6
1996	6
1997	3
1998	3
1999	1
2000	9
2001	5
2002	3
2003	4
2004	2
2005	4
2006	4
2007	1
2008	2
2009	1
2010	1
2011	2
2015	3
2016	2
2024	0

1

A novel series of P2T purinoceptor antagonists: definition of the role of ADP in arterial thrombosis.

Humphries RG, Robertson MJ, Leff P. Humphries RG, et al. Trends Pharmacol Sci. 1995 Jun;16(6):179-81. doi: 10.1016/s0165-6147(00)89018-5. Trends Pharmacol Sci. 1995. PMID: 7652925 Review. No abstract available.

2

Pharmacological profile of the novel P2T-purinoceptor antagonist, FPL 67085 in vitro and in the anaesthetized rat in vivo.

Humphries RG, Tomlinson W, Clegg JA, Ingall AH, Kindon ND, Leff P. Humphries RG, et al. Br J Pharmacol. 1995 Jul;115(6):1110-6. doi: 10.1111/j.1476-5381.1995.tb15925.x. Br J Pharmacol. 1995. PMID: 7582510 Free PMC article.

3

FPL 66096: a novel, highly potent and selective antagonist at human platelet P2T-purinoceptors.

Humphries RG, Tomlinson W, Ingall AH, Cage PA, Leff P. Humphries RG, et al. Br J Pharmacol. 1994 Nov;113(3):1057-63. doi: 10.1111/j.1476-5381.1994.tb17100.x. Br J Pharmacol. 1994. PMID: 7858849 Free PMC article.

4

Clinical pharmacology of the adenosine diphosphate (ADP) receptor antagonist, clopidogrel.

Schrör K. Schrör K. Vasc Med. 1998;3(3):247-51. doi: 10.1177/1358836X9800300312. Vasc Med. 1998. PMID: 9892518 Review.

5

The platelet P2 receptors in thrombosis.

Gachet C, Hechler B. Gachet C, et al. Semin Thromb Hemost. 2005 Apr;31(2):162-7. doi: 10.1055/s-2005-869521. Semin Thromb Hemost. 2005. PMID: 15852219 Review.

6

On the mechanism of plasmin-induced platelet aggregation. Implications of the dual role of granule ADP.

Ishii-Watabe A, Uchida E, Mizuguchi H, Hayakawa T. Ishii-Watabe A, et al. Biochem Pharmacol. 2000 Jun 1;59(11):1345-55. doi: 10.1016/s0006-2952(00)00279-3. Biochem Pharmacol. 2000. PMID: 10751543

7

The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties.

Sugidachi A, Asai F, Ogawa T, Inoue T, Koike H. Sugidachi A, et al. Br J Pharmacol. 2000 Apr;129(7):1439-46. doi: 10.1038/sj.bjp.0703237. Br J Pharmacol. 2000. PMID: 10742300 Free PMC article.

8

Advantages of fast-acting ADP receptor blockade in ischemic heart disease.

Nurden AT, Nurden P. Nurden AT, et al. Arterioscler Thromb Vasc Biol. 2003 Feb 1;23(2):158-9. doi: 10.1161/01.atv.0000053387.06709.32. Arterioscler Thromb Vasc Biol. 2003. PMID: 12588753 Review. No abstract available.

9

The P2 receptors in platelet function.

Hechler B, Cattaneo M, Gachet C. Hechler B, et al. Semin Thromb Hemost. 2005 Apr;31(2):150-61. doi: 10.1055/s-2005-869520. Semin Thromb Hemost. 2005. PMID: 15852218 Review.

10

Human erythroleukemic (HEL) cells express a platelet P2T-like ADP receptor.

Shi XP, Yin KC, Gardell SJ. Shi XP, et al. Thromb Res. 1995 Feb 1;77(3):235-47. doi: 10.1016/0049-3848(95)91611-n. Thromb Res. 1995. PMID: 7740516

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

73 results

Results by year